435 related articles for article (PubMed ID: 23666920)
21. Treatment with a farnesyltransferase inhibitor improves survival in mice with a Hutchinson-Gilford progeria syndrome mutation.
Yang SH; Qiao X; Fong LG; Young SG
Biochim Biophys Acta; 2008; 1781(1-2):36-9. PubMed ID: 18082640
[TBL] [Abstract][Full Text] [Related]
22. Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome.
Hamczyk MR; Villa-Bellosta R; Gonzalo P; Andrés-Manzano MJ; Nogales P; Bentzon JF; López-Otín C; Andrés V
Circulation; 2018 Jul; 138(3):266-282. PubMed ID: 29490993
[TBL] [Abstract][Full Text] [Related]
23. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome.
Mallampalli MP; Huyer G; Bendale P; Gelb MH; Michaelis S
Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14416-21. PubMed ID: 16186497
[TBL] [Abstract][Full Text] [Related]
24. Blocking protein farnesylation improves nuclear shape abnormalities in keratinocytes of mice expressing the prelamin A variant in Hutchinson-Gilford progeria syndrome.
Wang Y; Ostlund C; Worman HJ
Nucleus; 2010; 1(5):432-9. PubMed ID: 21326826
[TBL] [Abstract][Full Text] [Related]
25. Atypical progeroid syndrome due to heterozygous missense LMNA mutations.
Garg A; Subramanyam L; Agarwal AK; Simha V; Levine B; D'Apice MR; Novelli G; Crow Y
J Clin Endocrinol Metab; 2009 Dec; 94(12):4971-83. PubMed ID: 19875478
[TBL] [Abstract][Full Text] [Related]
26. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome.
Scaffidi P; Misteli T
Nat Med; 2005 Apr; 11(4):440-5. PubMed ID: 15750600
[TBL] [Abstract][Full Text] [Related]
27. p.Pro4Arg mutation in LMNA gene: a new atypical progeria phenotype without metabolism abnormalities.
Guo H; Luo N; Hao F; Bai Y
Gene; 2014 Aug; 546(1):35-9. PubMed ID: 24861648
[TBL] [Abstract][Full Text] [Related]
28. Nuclear localization signal deletion mutants of lamin A and progerin reveal insights into lamin A processing and emerin targeting.
Wu D; Flannery AR; Cai H; Ko E; Cao K
Nucleus; 2014; 5(1):66-74. PubMed ID: 24637396
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel RNA isoforms of LMNA.
DeBoy E; Puttaraju M; Jailwala P; Kasoji M; Cam M; Misteli T
Nucleus; 2017 Sep; 8(5):573-582. PubMed ID: 28857661
[TBL] [Abstract][Full Text] [Related]
30. Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis.
Csoka AB; English SB; Simkevich CP; Ginzinger DG; Butte AJ; Schatten GP; Rothman FG; Sedivy JM
Aging Cell; 2004 Aug; 3(4):235-43. PubMed ID: 15268757
[TBL] [Abstract][Full Text] [Related]
31. Defective lamin A-Rb signaling in Hutchinson-Gilford Progeria Syndrome and reversal by farnesyltransferase inhibition.
Marji J; O'Donoghue SI; McClintock D; Satagopam VP; Schneider R; Ratner D; Worman HJ; Gordon LB; Djabali K
PLoS One; 2010 Jun; 5(6):e11132. PubMed ID: 20559568
[TBL] [Abstract][Full Text] [Related]
32. Hutchinson-Gilford progeria syndrome.
Ullrich NJ; Gordon LB
Handb Clin Neurol; 2015; 132():249-64. PubMed ID: 26564085
[TBL] [Abstract][Full Text] [Related]
33. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
[TBL] [Abstract][Full Text] [Related]
34. Epidermal expression of the truncated prelamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skin.
Wang Y; Panteleyev AA; Owens DM; Djabali K; Stewart CL; Worman HJ
Hum Mol Genet; 2008 Aug; 17(15):2357-69. PubMed ID: 18442998
[TBL] [Abstract][Full Text] [Related]
35. Laminopathies and atherosclerosis.
Al-Shali KZ; Hegele RA
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1591-5. PubMed ID: 15205220
[TBL] [Abstract][Full Text] [Related]
36. New Lmna knock-in mice provide a molecular mechanism for the 'segmental aging' in Hutchinson-Gilford progeria syndrome.
Jung HJ; Tu Y; Yang SH; Tatar A; Nobumori C; Wu D; Young SG; Fong LG
Hum Mol Genet; 2014 Mar; 23(6):1506-15. PubMed ID: 24203701
[TBL] [Abstract][Full Text] [Related]
37. A humanized yeast system to analyze cleavage of prelamin A by ZMPSTE24.
Spear ED; Alford RF; Babatz TD; Wood KM; Mossberg OW; Odinammadu K; Shilagardi K; Gray JJ; Michaelis S
Methods; 2019 Mar; 157():47-55. PubMed ID: 30625386
[TBL] [Abstract][Full Text] [Related]
38. Hutchinson-Gilford progeria patient-derived cardiomyocyte model of carrying LMNA gene variant c.1824 C > T.
Perales S; Sigamani V; Rajasingh S; Czirok A; Rajasingh J
Cell Tissue Res; 2023 Oct; 394(1):189-207. PubMed ID: 37572165
[TBL] [Abstract][Full Text] [Related]
39. Altered splicing in prelamin A-associated premature aging phenotypes.
De Sandre-Giovannoli A; Lévy N
Prog Mol Subcell Biol; 2006; 44():199-232. PubMed ID: 17076270
[TBL] [Abstract][Full Text] [Related]
40. Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts.
Gabriel D; Roedl D; Gordon LB; Djabali K
Aging Cell; 2015 Feb; 14(1):78-91. PubMed ID: 25510262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
